TY - JOUR
KW - Adult
KW - Aged
KW - Buprenorphine/therapeutic use
KW - Cell Phones/utilization
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment/methods
KW - Patient Preference
KW - Surveys and Questionnaires
KW - Telemedicine/methods
KW - Text Messaging
AU - B. Tofighi
AU - E. Grossman
AU - E. Buirkle
AU - J. McNeely
AU - M. Gourevitch
AU - J. D. Lee
A1 - 
AB - BACKGROUND: Integrating mobile phone technologies in addiction treatment is of increasing importance and may optimize patient engagement with their care and enhance the delivery of existing treatment strategies. Few studies have evaluated mobile phone and text message (TM) use patterns in persons enrolled in addiction treatment, and none have assessed the use in safety net, office-based buprenorphine practices. METHODS: A 28-item, quantitative and qualitative semistructured survey was administered to opiate-dependent adults in an urban, publicly funded, office-based buprenorphine program. Survey domains included demographic characteristics, mobile phone and TM use patterns, and preferences pertaining to their recovery. RESULTS: Surveyors approached 73 of the 155 eligible subjects (47%); 71 respondents completed the survey. Nearly all participants reported mobile phone ownership (93%) and TM use (93%), and most reported "very much" or "somewhat" comfort sending TM (79%). Text message contact with 12-step group sponsors, friends, family members, and counselors was also described (32%). Nearly all preferred having their providers' mobile phone number (94%), and alerting the clinic via TM in the event of a potential relapse to receive both supportive TM and a phone call from their buprenorphine provider was also well received (62%). CONCLUSIONS: Mobile phone and TM use patterns and preferences among this sample of office-based buprenorphine participants highlight the potential of adopting patient-centered mobile phone-based interventions in this treatment setting.
BT - Journal of addiction medicine
C5 - Opioids & Substance Use; HIT & Telehealth
CP - 3
CY - United States
DO - 10.1097/ADM.0000000000000121
IS - 3
JF - Journal of addiction medicine
N2 - BACKGROUND: Integrating mobile phone technologies in addiction treatment is of increasing importance and may optimize patient engagement with their care and enhance the delivery of existing treatment strategies. Few studies have evaluated mobile phone and text message (TM) use patterns in persons enrolled in addiction treatment, and none have assessed the use in safety net, office-based buprenorphine practices. METHODS: A 28-item, quantitative and qualitative semistructured survey was administered to opiate-dependent adults in an urban, publicly funded, office-based buprenorphine program. Survey domains included demographic characteristics, mobile phone and TM use patterns, and preferences pertaining to their recovery. RESULTS: Surveyors approached 73 of the 155 eligible subjects (47%); 71 respondents completed the survey. Nearly all participants reported mobile phone ownership (93%) and TM use (93%), and most reported "very much" or "somewhat" comfort sending TM (79%). Text message contact with 12-step group sponsors, friends, family members, and counselors was also described (32%). Nearly all preferred having their providers' mobile phone number (94%), and alerting the clinic via TM in the event of a potential relapse to receive both supportive TM and a phone call from their buprenorphine provider was also well received (62%). CONCLUSIONS: Mobile phone and TM use patterns and preferences among this sample of office-based buprenorphine participants highlight the potential of adopting patient-centered mobile phone-based interventions in this treatment setting.
PP - United States
PY - 2015
SN - 1935-3227; 1932-0620
SP - 217
EP - 221
EP - 
T1 - Mobile phone use patterns and preferences in safety net office-based buprenorphine patients
T2 - Journal of addiction medicine
TI - Mobile phone use patterns and preferences in safety net office-based buprenorphine patients
U1 - Opioids & Substance Use; HIT & Telehealth
U2 - 25918966
U3 - 10.1097/ADM.0000000000000121
VL - 9
VO - 1935-3227; 1932-0620
Y1 - 2015
ER -